PARTNERS
AMRA - Expertise Partner
AMRA Medical is a health informatics and precision medicine company that is pioneering body composition analysis, providing cutting-edge solutions to advance both clinical research and patient care initiatives. AMRA’s gold-standard technology delivers multiple fat and muscle biomarkers - derived simply from rapid whole-body MRI scans. AMRA is committed to driving transformative care and simplifying vital decision-making in both research and clinical settings by offering support services via their innovative platform to help advance disease research in obesity, and beyond.
Antaros Medical - Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems
to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal and metabolic diseases and oncology.
Evidation - Expertise Partner
Evidation is redefining real-world data through direct, interactive relationships with millions of individuals. Through continuous engagement, Evidation captures longitudinal data to provide a more complete picture of health, including patient-reported and functional outcomes, connected device data, clinical records, and biosamples. Its privacy-first platform supports a right-patient, right-time approach to data collection, enabling faster research, stronger evidence, and better product decisions. Founded in 2012, Evidation is headquartered in California.
Ovation - Innovation Partner
Ovation is a life science data company committed to unlocking the potential of human genomic data to accelerate precision medicine development. By providing access to high-quality multi-omic data linked to rich, longitudinal phenotypic data at scale, Ovation helps life sciences researchers advance drug discovery and development more efficiently. Ovation collaborates with a broad network of clinical laboratories to streamline biobanking and scalable sample processing, generating robust molecular and phenotypically characterized longitudinal datasets.
Perspectum - Innovation Partner
Perspectum is a global medical imaging company delivering innovative solutions for clinical trials. Taking a holistic approach to obesity and metabolic diseases, the company leverages advanced multi-organ and body composition MRI imaging to provide insights into fat distribution, muscle quality, and organ health, allowing trial endpoints to move beyond weight loss alone. Backed by an extensive scanner network in over 750 locations worldwide, Perspectum has supported over 30 Phase 2b and Phase 3 trials, demonstrating proven scalability for large-scale clinical studies.
Curi Bio - Innovation Partner
Curi Bio unlocks novel workflows and critical human data to inform R&D decisionmaking. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/MLenabled insights, Curi Bio merges functional and analytical assessments for assessing drug safety, efficacy, and potency.
Physiogenex - Innovation Partner
Physiogenex is a preclinical CRO providing original and benchmarked animal models of obesity/type 2 diabetes and related co-morbidities: MASH, dyslipidemia, inflammation, diabetic nephropathy, HFpEF and atherosclerosis. For >20 years, we have been evaluating the efficacy of our clients’ drugs using goldstandard experiments in our validated preclinical models. Our customers benefitfrom our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners. Our expertise – your success.
Truveta - Event Partner
Truveta is a real-world intelligence company transforming medical science with unprecedented data and predictive AI. We power breakthrough discoveries, accelerate regulatory-grade evidence, and unlock real-time insights from a dataset uniquely built with and owned by US health systems—united by a mission of Saving Lives with Data.